This study is a randomized controlled crossover study evaluating the effect of spironolactone, a mineralocorticoid receptor antagonist for the treatment of nonresolving central serous chorioretinopathy. Spironolactone significantly reduced both serous retinal detachment and choroidal thickness as compared with placebo. Larger clinical trials are needed to confirm these promising results.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.